A 41-year-old woman presented unconscious with fixed dilated pupils following a massive overdose of carbamazepine and an unknown quantity of venlafaxine prescribed for the management of bipolar affective disorder. Her course in the intensive care unit was marked by a number of complications related to the overdose including prolonged coma, seizures and cardiac arrest. The patient eventually recovered to leave hospital.
The persistence at 24 hours of fixed, dilated pupils in an unconscious patient is generally a poor prognostic feature 1, 2 . The aetiology is varied but unifying literature on this subject is scant. This case report outlines another cause, potentially recoverable.
Carbamazepine is an iminostilbene anticonvulsant related to the tricyclic antidepressants. It reduces the permeability of neurones to sodium and potassium ions and inhibits the re-uptake of noradrenaline 3 . Established indications for its use include partial and generalized epilepsy and neuralgias. More recently carbamazepine has been used as an adjunct in the management of mood disorders [3] [4] [5] [6] . Thus, its clinical use and related complications such as overdose may be expected to increase.
Venlafaxine is a serotonin and noradrenaline re-uptake inhibitor used as an antidepressant. Overdose with either agent can lead to somnolence, seizures, central nervous system (CNS) depression, tachycardia, haemodynamic instability and rhabdomyolysis [3] [4] [5] [6] [7] [8] .
CASE HISTORY
A 41-year-old Maori woman was brought in by ambulance to a Sydney hospital about two hours after she had ingested an overdose of carbamazepine, between 142 and 192 tablets (28.4 to 38.4 g), and an unknown quantity of venlafaxine.
The history obtained from her partner revealed depression on a background of recent life stresses. A suicide attempt in December 1997 led to a psychiatric admission during which a diagnosis of bipolar affective disorder was made. Treatment with electroconvulsive therapy, venlafaxine, lithium and sodium valproate was instituted. She had remained on venlafaxine, 150 mg bd po, alone until three days prior to presentation when carbamazepine 200mg bd po was added by her psychiatrist for partially treated depression. There was no evidence of suicidal ideation at that consultation. The patient was a current smoker (25 pack year), had no history of cardiac problems, diabetes or epilepsy, took no other medication, had no known allergies and drank alcohol occasionally. On initial clinical examination she was unconscious with a Glasgow coma score (GCS) of 5, fixed dilated pupils and generalized hyporeflexia though flexor plantar responses were elicited. There was no neck stiffness or rash. She was breathing spontaneously and was haemodynamically stable and well perfused. Investigations yielded a blood carbamazepine level of 190 µmol/l (therapeutic range: 16 to 40 µmol/l). Serum lithium, paracetamol and ethanol levels were negligible. Urine drug screen was positive for carbamazepine and venlafaxine. Liver function tests and serum electrolytes, creatinine and magnesium levels were within normal limits. Blood glucose level was 10.4 mmol/l. The full blood count revealed a mild leucocytosis (14.4x10 9 /l). The coagulation profile was normal. Baseline electrocardiogram (ECG) showed sinus rhythm with no acute changes. The chest roentgenogram demonstrated clear lung fields.
The patient was intubated and ventilated. Gastric content aspiration and activated charcoal administration were commenced via a nasogastric tube. An arterial line was inserted for haemodynamic monitor-ing. She was transferred to the intensive care unit (ICU) at Royal North Shore Hospital (RNSH).
On arrival, her GCS was 3, an inoconstrictor infusion was required for hypotension and there was a sinus tachycardia. The patient had a severe lactic acidosis. Arterial blood gases on 50% oxygen were pH 7.11, P a CO 2 35 mmHg, P a O 2 154 mmHg, base excess -18, bicarbonate 11 mmol/l. Lactate was 15 mmol/l (range: 0.63 to 2.44 mmol/l). Sodium bicarbonate was administered. She was hypokalaemic (3.1 mmol/l) and hyperglycaemic. Serum creatine kinase (CK) level was 191U/l (range: 30 to 190U/l). Charcoal was continued.
On day 1 following the overdose, the carbamazepine level peaked at 295 µmol/l. Status epilepticus occurred. The electroencephalogram (EEG) revealed generalized seizures each of 10 to 20 seconds duration with associated clonic movements. In between, the EEG was flat and featureless. Treatment included clonazepam, phenytoin and paralysis with EEG monitoring. The patient remained on noradrenaline, a pulmonary artery (PA) catheter was inserted and dobutamine commenced. Chest X-ray revealed diffuse bilateral airspace changes suggestive of non-cardiogenic pulmonary oedema and/or aspiration.
On day 2, a cardiac arrest occurred and ECG tracing revealed a bizarre, broad complex rhythm. Cardiac massage, adrenaline, calcium chloride and metaraminol were required to re-establish cardiac output and her condition stabilized on continued inotropes. Prior to this event, serum potassium was 4.7 mmol/l and magnesium 1.14 mmol/l.
On day 3 a fever developed. Haemophilus influenzae and Streptococcus pneumoniae were cultured from sputum and treated. No further seizure activity was observed. Inotropes were ceased. Due to continued CNS irritability a cerebral CT scan was performed on day 4. This revealed mild cerebral oedema. Chest X-ray changes persisted.
The patient remained febrile (T>38.5°C) and ventilated. Subsequent cultures were negative. By day 7, CK levels had risen significantly. Increased muscle tone was noted clinically and a leukocytosis developed. A diagnosis of central hyperpyrexia, possibly neuroleptic malignant syndrome secondary to carbamazepine was made. Bromocriptine was started and improvement was temporally related to its commencement. Carbamazepine levels returned to the therapeutic range eight days post overdose. On day 12 she was extubated. CK peaked at 20590 U/l on day 13. She spent a total of 15 days in the ICU.
Though depression persisted, the patient made a good recovery. Twenty-nine days following initial admission, she was transferred to a psychiatric unit in her own area.
DISCUSSION
Our patient had a protracted course in the intensive care unit. Complications relating to her overdose included CNS depression with fixed dilated pupils, respiratory depression necessitating mechanical ventilation, severe lactic acidosis, status epilepticus, cardiac arrest and haemodynamic instability requiring inotropic support, pulmonary oedema, prolonged hyperglycaemia and central hyperpyrexia.
The features of carbamazepine poisoning have been reported previously 3, [8] [9] . Sinus tachycardia is generally the only frequent cardiovascular effect though arrhythmias have been documented 5 . Seizures, which are often multiple, may occur in the absence of previously documented epilepsy 4 . Ataxia, dysarthria, nystagmus, dystonias and varying degrees of CNS depression are common. Abnormal tendon reflexes are reported. Irritability and hallucinations have occurred after massive overdose during emergence from coma. The EEG may show diffuse slowing. Hypothermia, or hyperthermia and rhabdomyolysis, as part of neuroleptic malignant syndrome, may develop. O'Griofa and Voris have reported a case of this syndrome apparently related to carbamazepine use alone 6 . Other features include hyponatraemia resulting from inappropriate ADH secretion (SIADH), metabolic acidosis and hypokalaemia. Hyperglycaemia complicating overdose has been noted in a previous Australian series 4 . Venlafaxine may also have contributed to the clinical scenario as overdose can lead to somnolence, CNS depression, seizures, tachycardia, hypotension, rhabdomyolysis and serotonin syndrome 7 .
Pupillary pathways are relatively resistant to metabolic insult. Hence, the light reflex is a most important sign and may distinguish structural from metabolic coma. However, there are several causes for fixed, dilated pupils in potentially reversible coma and these include pharmacological agents ( Table 1) . Our patient's pupils were documented as fixed and dilated or, at best, poorly responsive for over 48 hours. Notably though, drug induced coma has a more favourable prognosis compared with other aetiologies provided that serious complications are avoided or treated promptly 2 .
Holmes-Adie pupils are large, slightly irregular and do not react to light 12 . The condition is generally benign and unilateral, and is due to destruction of the ciliary ganglion. There is a female predominance with a reported rapid onset in adulthood.
Bilateral oculomotor nerve palsies may result from central herniation through the tentorial notch or from space-occupying lesions or infarcts involving midbrain 13 . Loss of the light reflex is the earliest sign, though ptosis and external ophthalmoplegia may occur.
The topical cholinergic pilocarpine may be used to distinguish between various causes of fixed, dilated pupils. This agent constricts pupils in the presence of third nerve palsies, anoxic brain injury or Holmes-Adie syndrome but is ineffective if the cause is pharmacological mydriasis. This is because pilocarpine acts directly on the smooth muscle constricting the pupil. However, these smooth muscle receptors are blocked by anticholinergic agents, hence a diminished or absent response 1, 10 . Carbamazepine has anticholinergic-like effects 8 that can cause mydriasis and unresponsiveness to light. We consider this agent to be the predominant cause of our patient's prolonged nonreactive mydriasis. Later, status epilepticus and treatment given in the management of cardiac arrest may have contributed.
Unconsciousness with persistence of fixed, dilated pupils and the development of multiple lifethreatening complications are generally regarded as poor prognostic features. However, our case demonstrates that following massive carbamazepine overdose, excellent recovery is possible.
TABLE 1
Causes of fixed dilated pupils in potentially reversible coma [10] [11] [12] [13] 
